Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

NCT: NCT07178210 · RECRUITING

NCT IDNCT07178210
StatusRECRUITING
Start Date2026-04-30
Completion2027-10-30
SponsorMMI (Medical Microinstruments, Inc.) (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑